These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25692941)

  • 1. Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma.
    Barochia AV; Kaler M; Cuento RA; Gordon EM; Weir NA; Sampson M; Fontana JR; MacDonald S; Moss J; Manganiello V; Remaley AT; Levine SJ
    Am J Respir Crit Care Med; 2015 May; 191(9):990-1000. PubMed ID: 25692941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics.
    Barochia AV; Gordon EM; Kaler M; Cuento RA; Theard P; Figueroa DM; Yao X; Weir NA; Sampson ML; Stylianou M; Choy DF; Holweg CTJ; Remaley AT; Levine SJ
    J Lipid Res; 2017 Aug; 58(8):1713-1721. PubMed ID: 28655726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Potential Link between Serum Low-Density Lipoproteins and Asthma.
    Scichilone N; Rizzo M
    Am J Respir Crit Care Med; 2015 Jul; 192(2):261-2. PubMed ID: 26177177
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply: A Potential Link between Serum Low-Density Lipoproteins and Asthma.
    Barochia AV; Levine SJ
    Am J Respir Crit Care Med; 2015 Jul; 192(2):262-3. PubMed ID: 26177178
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
    Matthan NR; Welty FK; Barrett PH; Harausz C; Dolnikowski GG; Parks JS; Eckel RH; Schaefer EJ; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1092-7. PubMed ID: 15087307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study.
    Holme I; Høstmark AT; Anderssen SA
    J Intern Med; 2007 Aug; 262(2):235-43. PubMed ID: 17645591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.
    Wallenfeldt K; Bokemark L; Wikstrand J; Hulthe J; Fagerberg B
    Stroke; 2004 Oct; 35(10):2248-52. PubMed ID: 15345795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
    Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
    Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome.
    Olson EJ; Pearce GL; Jones NP; Sprecher DL
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2289-94. PubMed ID: 22814748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting "Good" and "Bad" Cholesterol. The Battle over Flow through Arteries Now Shifts to Flow through Airways.
    Fessler MB
    Am J Respir Crit Care Med; 2015 May; 191(9):969-70. PubMed ID: 25932757
    [No Abstract]   [Full Text] [Related]  

  • 16. The apolipoprotein B/apolipoprotein A-I ratio as a potential marker of plasma atherogenicity.
    Kaneva AM; Potolitsyna NN; Bojko ER; Odland JØ
    Dis Markers; 2015; 2015():591454. PubMed ID: 25852220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Lefrandt JD
    Clin Biochem; 2014 Nov; 47(16-17):170-5. PubMed ID: 25149194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin levels and lipoprotein profiles in patients with cholelithiasis.
    Saraç S; Atamer A; Atamer Y; Can AS; Bilici A; Taçyildiz İ; Koçyiğit Y; Yenice N
    J Int Med Res; 2015 Jun; 43(3):385-92. PubMed ID: 25762517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
    van der Steeg WA; Holme I; Boekholdt SM; Larsen ML; Lindahl C; Stroes ES; Tikkanen MJ; Wareham NJ; Faergeman O; Olsson AG; Pedersen TR; Khaw KT; Kastelein JJ
    J Am Coll Cardiol; 2008 Feb; 51(6):634-42. PubMed ID: 18261682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus.
    Tan HC; Tai ES; Sviridov D; Nestel PJ; Ng C; Chan E; Teo Y; Wai DC
    J Clin Lipidol; 2011; 5(6):467-73. PubMed ID: 22108150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.